We are live on ! Find out more
ZNTL icon

Zentalis Pharmaceuticals
ZNTL

107 hedge funds and large institutions have $1.94B invested in Zentalis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

840% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 5

215% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 13

85% more capital invested

Capital invested by funds: $1.05B → $1.94B (+$889M)

62% more funds holding

Funds holding: 66 → 107 (+41)

11.65% more ownership

Funds ownership: 80.2% → 91.85% (+12%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
107
Holders Change
+41
Holders Change %
+62.12%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
47
Increased
41
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$146M
2
BlackRock
BlackRock
New York
+$59.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$54.7M
4
State Street
State Street
Massachusetts
+$32.9M
5
APM
Avidity Partners Management
Texas
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$64.6M
2
FCM
Farallon Capital Management
California
-$32.4M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$18.2M
4
Citadel Advisors
Citadel Advisors
Florida
-$8.38M
5
MC
Mayo Clinic
Minnesota
-$3.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
$980K +$851K +18,876 New
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$881K +$479K +10,625 +168%
Wells Fargo
53
Wells Fargo
California
$876K +$380K +8,415 +100%
CWM
54
Cornerstone Wealth Management
Missouri
$811K +$704K +15,607 New
DekaBank Deutsche Girozentrale
55
DekaBank Deutsche Girozentrale
Germany
$725K +$600K +13,300 New
JP Morgan Chase
56
JP Morgan Chase
New York
$701K +$415K +9,193 +214%
Two Sigma Advisers
57
Two Sigma Advisers
New York
$680K +$591K +13,100 New
ProShare Advisors
58
ProShare Advisors
Maryland
$656K +$570K +12,638 New
Citigroup
59
Citigroup
New York
$625K +$517K +11,455 +2,027%
VOYA Investment Management
60
VOYA Investment Management
Georgia
$621K +$539K +11,949 New
MIM
61
MetLife Investment Management
New Jersey
$615K +$305K +6,771 +133%
Verition Fund Management
62
Verition Fund Management
Connecticut
$601K -$353K -7,830 -40%
UBS AM
63
UBS AM
Illinois
$597K +$519K +11,500 New
Squarepoint
64
Squarepoint
New York
$562K +$488K +10,825 New
EAM
65
Erste Asset Management
Austria
$534K +$442K +9,800 New
SCM
66
Silverarc Capital Management
Massachusetts
$519K +$451K +10,000 New
Norges Bank
67
Norges Bank
Norway
$511K +$444K +9,844 New
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$458K +$398K +8,820 New
CF
69
CNA Financial
Illinois
$455K +$17.1K +380 +5%
JF
70
Jump Financial
Illinois
$447K +$388K +8,600 New
Ensign Peak Advisors
71
Ensign Peak Advisors
Utah
$431K +$374K +8,300 New
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$430K +$215K +4,774 +136%
Brown Advisory
73
Brown Advisory
Maryland
$413K +$359K +7,958 New
SG Americas Securities
74
SG Americas Securities
New York
$410K -$1.96M -43,520 -85%
VF
75
Virtu Financial
New York
$371K +$322K +7,142 New
1 2
3
4 5

ZNTL Hedge Fund Activity: Q4 2020 in Review

107 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Zentalis Pharmaceuticals (ZNTL) for Q4 2020, worth a combined $1.94B — up 85% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ZNTL positions and 5 closed out — a net gain of 42 holders — while 41 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was Viking Global Investors, cutting an estimated $64.6M.

  • 107 institutional investors held Zentalis Pharmaceuticals (ZNTL) as of Q4 2020, up from 66 in Q3 2020.
  • Funds reported $1.94B of Zentalis Pharmaceuticals stock for Q4 2020, up 85% quarter-over-quarter.
  • 47 funds opened new Zentalis Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +42 holders.
  • The largest Zentalis Pharmaceuticals buyer in Q4 2020 was Fidelity Investments, an estimated $146M added.
  • The largest Zentalis Pharmaceuticals seller in Q4 2020 was Viking Global Investors, an estimated $64.6M sold.

Based on aggregated 13F filings for Q4 2020.